Investment Thesis
Fractyl Health shows fundamental distress with zero revenue despite operating as a surgical instruments company, indicating failure to commercialize products or complete loss of revenue-generating capability. The company is burning $23M annually in free cash flow while operating at a $20.8M loss, making the current positive net income ($9.2M) appear driven by one-time gains rather than sustainable operations.
Strengths
- Strong cash position of $63.2M provides near-term runway
- Fortress balance sheet with zero long-term debt and 4.28x current ratio
- Positive stockholders' equity of $21.4M
Risks
- Complete revenue collapse: $0.00 in revenue (-100% YoY) indicates product commercialization failure or operational cessation
- Unsustainable cash burn: -$23.0M free cash flow annually provides only ~2.7 years of runway at current rates
- Operating losses of -$20.8M with positive net income suggests non-operating gains masking fundamental business failure
- Zero insider activity in 90 days suggests management loss of confidence
- Medical device sector requires revenue generation; zero revenue is terminal
Key Metrics to Watch
- Quarterly revenue and path to commercialization
- Operating cash flow trend and burn rate acceleration/deceleration
- Cash and equivalents balance and runway calculation
- Operating loss magnitude and whether it stabilizes
Financial Metrics
Revenue
0.0
Net Income
9.2M
EPS (Diluted)
$0.06
Free Cash Flow
-23.0M
Total Assets
99.4M
Cash
63.2M
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
43.1%
ROA
9.3%
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
4.28x
Quick Ratio
4.27x
Debt/Equity
0.00x
Debt/Assets
78.5%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-14T08:28:07.682813 |
Data as of: 2026-03-31 |
Powered by Claude AI